SCHEMBL28954752

SCHEMBL28954752

CC(C)(O)c1ccccc1CCC(Cl)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR1 Q9Y271 3/20 0.66
▸ CYP2C8 P10632 2/20 0.66
▸ CYSLTR2 Q9NS75 2/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ RECQL P46063 1/20 0.66
▸ BLM P54132 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ ABCB11 O95342 1/20 0.66
▸ EGFR P00533 1/20 0.66
▸ ESR1 P03372 1/20 0.66
▸ NR3C1 P04150 1/20 0.66
▸ FYN P06241 1/20 0.66
▸ PGR P06401 1/20 0.66
▸ ADRB2 P07550 1/20 0.66
▸ ADRB1 P08588 1/20 0.66
▸ ADRA2A P08913 1/20 0.66
▸ ADORA3 P0DMS8 1/20 0.66
▸ CHRM1 P11229 1/20 0.66
▸ ADRB3 P13945 1/20 0.66
▸ ADRA2B P18089 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791965 1.00 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL1592780 1.00 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL29903285 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL201921 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL2734689 0.91 CYP2C8 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL30205136 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL990277 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL1150080 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL9926899 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL
SCHEMBL201920 0.91 CYSLTR1 (0.66) CYSLTR1CYP2C8CYSLTR2MEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115710221-A Synthesis method of montelukast sodium intermediate 宿迁盛基医药科技有限公司 2023-02-24 — — CN disclosed
Send feedback